TSS:Hg 60555.1

Basic information about the TSS

---

TSS ID: hg_60555.1 Species: human Chr: chr5		Start: 179678614 End: 179678665 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000681674.1 ENST00000681712.1 Distance: 0 GeneID: 821 HGNC/MGI_ID: HGNC:1473 UniProt_ID:

Gene_name: calnexin Gene_symbol: CANX Gene_synonyms: CNX IP90 P90 Gene_source: HGNC:1473

TATA-Box annotation

---

Distance to TSS:	2394
Nearest PromoterID:	NM_001164444
Entrez ID:	646019
Nearest Unigene:	Hs.535767
Nearest Refseq:	NM_001164444
Nearest Ensembl:	ENSG00000204659
Gene Name:	calnexin
Gene Alias:	-
Gene Description:	chibby family member 3
Gene Type:	protein-coding
CpG%:	0.145
GC%:	0.696517
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CANX p2@CANX p5@CANX p7@CANX p10@CANX
Sample		p1@CANX	p2@CANX	p5@CANX	p7@CANX	p10@CANX
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	352.79	3.90	2.34	2.14	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	365.79	4.65	2.23	1.82	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	375.39	4.24	1.35	2.31	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	318.31	3.53	1.66	1.66	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	352.30	1.57	0.90	1.80	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	348.47	4.07	1.36	2.71	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	426.62	3.70	0.44	1.96	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	370.60	4.12	0.73	1.70	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	333.83	2.78	0.64	2.35	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	266.63	0.00	0.58	1.16	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	232.43	0.81	0.81	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	259.38	3.25	0.41	1.22	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	187.63	1.13	0.32	0.16	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	214.55	3.46	0.60	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	164.66	1.54	0.22	0.88	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	193.90	4.02	0.50	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	160.09	1.09	0.66	0.22	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	185.60	3.80	0.42	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	184.47	3.73	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	183.99	1.96	0.75	0.45	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	197.54	1.60	0.53	0.80	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	207.84	2.59	1.38	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	197.76	1.42	1.03	0.13	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	173.51	1.94	0.97	0.73	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	181.88	2.84	0.00	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	151.61	1.27	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	196.71	2.75	0.55	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	216.66	4.72	0.71	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	170.57	2.58	0.97	0.48	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	184.22	2.53	0.36	0.36	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	158.26	1.88	1.05	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	153.57	1.76	0.59	0.20	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	188.66	1.90	0.42	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	257.97	1.81	1.32	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	169.04	2.62	0.75	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	168.63	2.30	0.77	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	186.39	2.45	0.41	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	169.85	2.01	0.00	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	164.49	2.16	0.27	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	149.32	3.36	0.48	1.20	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	173.15	1.18	0.94	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	203.78	2.34	0.59	0.59	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	150.16	2.74	1.27	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	171.86	2.45	0.70	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	163.23	1.20	0.40	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	158.20	3.26	0.47	1.40	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	167.93	0.72	0.96	0.72	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	160.35	0.89	0.89	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	184.56	1.20	0.96	1.20	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	188.45	1.42	0.61	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	239.80	3.48	0.82	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	232.60	6.45	0.22	2.00	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	951.47	27.98	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	184.53	1.06	0.35	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	198.83	2.65	0.33	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	515.11	18.46	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	337.54	5.05	0.46	3.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	177.61	2.59	0.32	2.59	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	164.76	2.57	0.32	2.89	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	339.48	7.23	0.63	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	200.24	2.12	0.00	3.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	210.86	2.24	1.12	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	599.50	35.03	1.59	2.39	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	351.66	2.72	1.02	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	202.75	2.27	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	161.52	3.19	0.00	1.42	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	775.87	32.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1074.06	31.59	7.90	7.90	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	152.10	1.95	0.98	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	158.68	4.96	0.00	1.49	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	153.40	1.41	0.00	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	205.01	3.64	0.99	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	152.81	2.17	0.62	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	164.49	1.53	0.00	0.31	0.61
Adipocyte - breast, donor1	11376-118A8	510.47	3.48	2.53	3.33	1.58
Adipocyte - breast, donor2	11327-117E4	394.17	7.22	2.25	2.73	0.64
Adipocyte - omental, donor1	11473-119C6	699.24	3.44	2.42	6.62	1.02
Adipocyte - omental, donor2	11474-119C7	378.98	3.74	4.48	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	499.36	4.02	3.01	2.34	0.00
Adipocyte - perirenal, donor1	11476-119C9	480.41	10.85	1.91	2.55	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	98.96	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	408.72	1.35	1.35	3.16	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	172.91	1.22	0.35	0.70	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	768.01	2.93	5.28	1.17	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	504.98	2.83	2.06	1.03	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	637.00	6.41	3.07	1.67	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	704.78	3.53	1.18	2.94	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	628.99	2.57	3.94	1.93	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	530.29	4.84	1.94	0.65	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	392.96	3.20	1.60	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	563.11	3.34	2.78	1.67	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	390.52	2.50	2.50	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	374.74	2.51	1.51	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	408.07	2.95	1.96	1.31	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	376.02	1.83	2.74	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	190.72	0.44	0.22	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	30.12	0.36	0.00	0.00	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	26.36	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	215.17	1.80	0.90	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	108.78	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	102.72	0.62	0.62	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	328.40	0.92	0.92	1.26	1.03
Anulus Pulposus Cell, donor2	11463-119B5	294.38	2.45	2.69	1.22	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	358.99	2.25	1.35	5.84	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	388.99	2.60	0.00	5.64	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	239.71	6.42	4.28	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	342.86	2.99	1.49	3.89	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	360.43	5.06	0.00	7.59	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	244.23	3.96	0.66	3.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	315.46	2.60	2.27	6.82	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	350.97	5.34	1.94	3.40	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	280.31	4.75	1.19	1.78	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	364.58	3.01	4.90	3.39	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	363.56	0.73	2.90	2.90	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	190.57	2.51	2.51	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	442.65	2.14	1.81	5.44	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	349.39	2.73	4.09	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	291.03	1.51	0.60	5.28	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	333.80	6.43	1.61	2.68	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	343.86	4.72	2.27	3.40	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	303.64	4.28	0.27	3.47	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	314.10	2.93	0.98	2.93	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	340.34	3.32	2.32	4.98	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	218.53	1.20	1.20	4.80	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	375.26	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	343.92	3.43	1.54	5.66	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	226.53	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	339.31	3.40	1.46	6.31	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	369.21	3.79	1.52	4.55	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	258.02	3.63	2.42	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	327.77	5.13	2.85	5.13	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	337.76	1.92	2.57	3.85	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	255.77	1.55	1.03	3.10	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	322.81	1.41	2.82	3.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	339.56	3.22	1.93	3.54	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	226.16	0.71	0.71	6.42	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	308.85	2.34	1.17	4.68	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	339.91	3.01	0.90	4.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	239.97	8.32	0.00	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	363.62	4.07	3.05	4.07	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	366.24	7.90	2.04	4.58	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	228.10	0.64	0.00	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	332.71	1.73	1.73	3.45	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	323.03	4.87	1.48	4.45	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	218.36	4.64	0.58	3.19	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	365.61	0.94	0.94	2.83	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	321.59	3.22	2.20	2.88	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	233.95	6.95	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	437.30	4.23	2.11	6.34	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	350.99	4.93	2.57	3.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	250.29	2.41	0.00	4.81	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	338.25	2.19	0.73	2.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	352.41	4.83	2.30	5.06	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	224.43	20.40	2.55	7.65	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	340.67	3.31	0.76	6.86	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	383.98	3.30	1.45	5.37	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	275.09	3.98	0.92	4.90	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	412.05	3.35	0.96	3.82	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	330.84	4.43	0.89	3.99	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	216.66	4.58	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	333.99	3.88	1.11	3.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	358.00	3.71	1.59	6.09	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	259.86	1.82	0.73	3.63	0.36
Astrocyte - cerebellum, donor1	11500-119F6	174.03	1.35	0.86	0.25	0.74
Astrocyte - cerebellum, donor2	11580-120F5	108.17	0.17	0.51	0.17	0.34
Astrocyte - cerebellum, donor3	11661-122F5	65.44	0.42	0.00	0.00	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	487.67	3.14	2.79	1.05	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	406.21	3.24	1.13	0.97	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	420.93	4.92	2.24	0.15	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	405.76	2.41	4.93	0.92	2.18
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	418.57	2.51	4.64	1.13	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	423.32	2.28	3.19	0.34	0.57
Basophils, donor1	12241-129G9	281.15	1.05	1.05	1.31	0.00
Basophils, donor2	12242-129H1	458.57	1.80	1.44	0.72	1.08
Basophils, donor3	12243-129H2	393.36	0.29	3.23	0.44	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	83.44	0.86	0.22	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	25.15	0.46	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	200.86	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	155.66	1.26	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	199.84	1.66	0.21	0.62	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	236.05	3.22	0.23	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	265.60	3.42	1.08	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	454.16	2.27	1.24	1.55	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	930.22	5.59	2.10	0.47	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	608.53	0.96	0.96	1.28	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	517.10	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	382.09	0.56	2.82	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	337.79	2.41	1.86	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	275.74	0.88	1.76	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	633.45	1.98	1.70	0.28	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	610.69	2.27	3.79	1.14	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	697.59	2.96	1.31	0.66	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	388.11	4.05	2.17	2.60	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	404.64	4.22	4.53	2.41	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	389.45	3.08	1.66	1.66	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	331.95	3.18	1.00	2.34	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	394.14	4.14	3.04	2.48	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	398.67	4.21	1.49	2.23	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	295.07	2.35	1.17	0.98	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	345.77	3.92	1.78	1.07	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	450.71	4.13	1.09	2.18	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	320.52	4.21	1.64	0.70	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	492.65	4.22	2.64	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	442.63	0.00	5.55	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	383.62	3.42	1.93	2.38	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	477.92	5.19	2.99	1.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	502.18	2.29	1.67	1.46	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	344.78	4.12	1.14	2.75	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	531.58	2.26	2.71	1.58	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	337.38	5.24	3.06	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	358.56	2.96	2.15	1.88	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	427.43	4.19	2.09	2.27	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	394.31	4.21	2.52	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	316.17	4.04	0.55	1.65	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	407.22	5.28	2.11	1.41	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	402.31	4.83	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	319.28	3.49	1.05	0.87	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	382.08	6.69	2.23	1.86	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	483.26	3.88	1.94	1.29	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	338.65	1.64	2.87	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	493.04	3.01	3.25	1.16	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	417.59	3.02	0.46	0.93	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	298.39	2.18	1.53	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	292.44	3.46	0.46	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	275.54	1.30	1.30	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	469.35	1.87	1.09	1.25	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	424.56	1.92	0.87	0.87	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	736.69	2.45	1.56	2.23	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	153.87	0.77	1.53	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	180.70	1.98	1.54	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	212.23	0.84	1.26	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	180.88	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	208.14	2.03	3.39	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	207.12	0.00	1.04	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	229.21	0.53	2.67	0.00	3.20
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	244.45	1.07	2.14	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	205.67	0.70	0.70	0.00	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	236.88	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	221.47	1.32	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	156.98	3.29	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	145.09	1.45	2.18	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	145.39	1.01	1.51	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	302.23	1.62	0.40	2.83	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	225.71	0.40	0.40	2.40	0.40
CD34+ Progenitors, donor1	11545-120B6	251.01	2.01	1.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	328.10	0.56	1.69	1.12	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	651.56	1.13	1.88	3.38	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	729.44	1.35	2.93	2.03	3.16
CD4+ T Cells, donor1	11225-116C1	241.73	0.36	1.07	0.71	1.07
CD4+ T Cells, donor2	11306-117C1	168.40	3.06	0.61	0.61	1.22
CD4+ T Cells, donor3	11382-118B5	196.11	1.83	2.13	0.00	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	236.86	0.77	0.26	0.00	2.04
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	254.69	2.02	0.45	0.00	1.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	192.02	0.86	0.29	0.00	2.87
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	169.72	0.00	0.00	0.00	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	191.73	0.00	1.40	0.00	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	164.81	3.30	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	352.04	2.89	1.01	0.58	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	197.59	0.68	0.85	0.85	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	175.23	0.81	0.81	0.16	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	144.80	0.00	1.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	181.33	0.70	0.70	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	197.11	2.64	0.88	0.44	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	326.35	1.69	1.26	0.00	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	220.03	1.87	0.42	0.00	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	209.50	1.34	1.67	0.00	2.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	212.92	1.63	0.82	0.27	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	244.39	1.61	0.00	0.00	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	181.12	3.59	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	410.35	1.48	1.11	0.00	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	296.12	1.08	1.08	0.22	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	293.58	2.10	2.10	0.21	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	188.08	0.00	0.51	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	196.26	1.73	0.87	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	287.20	1.74	0.87	0.00	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	302.86	1.48	0.99	0.00	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	299.11	1.85	1.85	0.00	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	242.87	1.40	0.00	1.40	6.98
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	444.19	1.11	0.83	0.00	3.32
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	488.82	1.47	1.23	0.00	4.42
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	315.70	0.00	0.00	1.54	10.78
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	366.00	1.43	1.07	0.00	3.58
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	368.41	1.38	0.00	0.00	5.54
CD8+ T Cells, donor1	11226-116C2	269.12	1.64	1.31	0.00	1.64
CD8+ T Cells, donor2	11307-117C2	177.20	1.50	1.50	0.38	1.88
CD8+ T Cells, donor3	11383-118B6	217.14	3.28	1.77	0.76	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	323.90	5.28	1.84	0.69	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	298.59	5.51	2.88	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	304.51	4.65	1.64	1.37	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	360.25	5.10	3.60	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	286.30	2.16	1.92	0.96	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	297.42	3.18	2.50	0.68	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	322.88	3.04	4.56	1.30	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	322.95	2.90	2.90	1.05	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	366.78	2.58	4.69	0.70	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	455.83	6.34	5.13	1.81	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	403.80	7.84	3.49	1.16	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	451.07	5.06	8.53	1.33	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	272.28	1.31	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	321.08	1.37	4.10	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	278.96	1.49	3.73	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	257.15	1.80	4.32	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	283.98	4.32	2.88	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	264.92	0.94	2.36	1.89	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	368.88	3.80	3.80	1.58	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	321.71	2.77	5.54	1.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	348.79	2.24	3.53	0.64	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	407.71	2.29	4.59	1.91	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	370.46	1.97	3.15	1.58	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	368.37	6.81	1.51	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	371.77	2.41	4.82	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	381.89	2.80	3.50	0.00	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	435.76	7.01	7.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	382.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	304.85	2.96	1.98	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	427.77	1.26	3.05	0.84	0.00
Chondrocyte - de diff, donor1	11261-116G1	547.73	4.85	3.12	2.77	1.73
Chondrocyte - de diff, donor2	11338-117F6	310.60	1.07	0.71	1.07	1.78
Chondrocyte - de diff, donor3	11410-118E6	298.90	2.39	1.14	2.73	0.80
Chondrocyte - re diff, donor2	11339-117F7	1052.82	11.64	8.95	10.74	1.79
Chondrocyte - re diff, donor3	11411-118E7	416.54	4.45	1.21	0.81	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	401.88	1.72	1.26	0.80	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	278.75	3.21	1.50	1.07	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	318.59	1.86	1.59	0.62	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	402.47	2.11	2.66	0.37	14.67
Corneal Epithelial Cells, donor1	11526-119I5	44.57	0.22	0.22	0.00	0.66
Corneal Epithelial Cells, donor2	11606-120I4	65.98	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	75.92	0.26	0.51	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	435.03	2.31	2.48	0.99	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	412.87	1.58	3.15	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	345.07	0.00	10.35	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	294.06	3.13	3.46	0.65	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	681.57	3.07	2.73	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	748.84	2.61	2.61	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	805.77	2.90	8.23	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	466.12	2.17	1.33	2.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	297.50	2.35	0.59	4.69	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	445.12	1.98	1.41	2.26	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	387.68	2.36	1.57	3.15	0.00
Endothelial Cells - Artery, donor1	11264-116G4	244.92	1.45	1.45	2.04	0.29
Endothelial Cells - Artery, donor2	11341-117F9	341.86	3.06	1.88	1.18	0.24
Endothelial Cells - Artery, donor3	11413-118E9	362.89	2.98	2.10	1.40	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	350.21	0.44	0.89	0.89	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	425.97	1.83	2.74	1.83	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	517.86	1.13	3.38	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	251.67	0.89	0.89	1.78	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	318.13	0.00	1.56	2.60	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	135.83	1.42	0.99	0.14	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	731.42	2.00	3.60	2.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	219.61	1.57	1.05	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	749.58	2.86	2.98	1.12	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	498.40	1.52	1.52	0.87	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	632.25	4.52	2.44	1.10	0.85
Endothelial Cells - Vein, donor1	11267-116G7	274.14	0.00	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	332.49	2.10	2.10	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	306.01	2.83	1.10	2.04	0.31
Eosinophils, donor1	12244-129H3	548.89	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	316.85	0.00	3.30	1.65	0.00
Eosinophils, donor3	12246-129H5	328.15	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	89.67	0.49	0.00	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	29.12	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	260.30	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	442.53	3.69	2.87	2.46	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	204.20	6.35	1.53	4.38	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	58.29	0.65	0.43	0.65	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	595.00	3.40	2.79	3.27	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	804.63	2.73	10.10	8.87	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	411.22	4.32	2.74	3.27	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	1509.01	13.70	8.17	5.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	455.78	4.65	1.00	1.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	295.76	1.81	1.81	0.91	0.91
Fibroblast - Cardiac, donor2	11345-117G4	267.56	1.52	3.03	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	257.24	1.73	2.21	3.15	0.63
Fibroblast - Cardiac, donor4	11452-119A3	532.86	1.82	3.64	1.52	0.61
Fibroblast - Cardiac, donor5	11456-119A7	453.81	3.30	2.41	0.63	0.25
Fibroblast - Cardiac, donor6	11460-119B2	407.33	4.40	0.91	0.61	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	380.80	1.34	1.61	0.94	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	372.75	3.45	2.16	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	304.68	1.46	1.46	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	201.58	0.23	0.69	0.46	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	488.46	1.87	0.68	0.51	2.04
Fibroblast - Dermal, donor1	11269-116G9	261.55	1.17	0.94	1.64	0.00
Fibroblast - Dermal, donor2	11346-117G5	306.12	0.47	1.89	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	200.31	1.81	1.09	0.60	0.00
Fibroblast - Dermal, donor4	11450-119A1	325.12	2.15	0.68	0.79	0.34
Fibroblast - Dermal, donor5	11454-119A5	392.52	3.84	1.40	0.87	0.35
Fibroblast - Dermal, donor6	11458-119A9	433.02	2.44	1.79	0.65	0.16
Fibroblast - Gingival, donor1	11237-116D4	473.51	0.83	1.46	1.46	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	403.22	4.45	1.83	3.93	0.52
Fibroblast - Gingival, donor2	11318-117D4	332.49	3.03	0.79	0.40	0.79
Fibroblast - Gingival, donor3	11394-118C8	423.97	1.84	0.68	0.77	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	573.47	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	385.71	4.23	2.11	0.70	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	506.35	3.27	1.71	1.25	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	451.93	4.33	1.22	1.08	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	182.09	0.00	0.00	1.41	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	425.57	1.90	1.32	1.61	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	512.01	2.86	1.50	1.91	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	666.28	4.83	2.52	2.52	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	412.19	2.93	1.17	0.73	0.88
Fibroblast - Lung, donor1	11270-116H1	103.31	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	334.24	4.48	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	192.25	0.84	1.27	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	193.26	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	163.64	0.00	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	30.51	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	445.35	1.22	0.41	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	43.94	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	214.43	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	454.48	1.94	0.97	0.39	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	442.76	2.12	1.06	0.61	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	759.77	1.53	1.84	2.14	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	480.08	1.91	0.76	0.38	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	372.86	2.97	1.35	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	479.44	3.94	2.78	1.39	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	376.58	2.43	1.88	2.43	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	291.58	0.81	0.61	0.81	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	109.59	1.34	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	242.75	1.19	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	1170.84	8.93	3.37	2.18	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	429.30	2.13	1.24	0.71	1.42
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	540.80	3.35	1.38	0.99	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1221.47	7.52	6.02	5.11	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	593.84	2.48	3.45	1.19	1.51
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	701.52	3.29	4.05	1.77	0.51
Fibroblast - skin normal, donor1	11553-120C5	481.40	1.97	2.95	1.64	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1612.28	7.82	9.22	9.82	0.60
Fibroblast - skin normal, donor2	11561-120D4	640.55	2.91	4.32	3.01	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	673.08	4.84	3.02	0.30	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	442.56	1.82	1.16	0.66	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	388.74	1.20	3.08	0.17	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1124.22	7.23	4.60	7.23	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	610.16	3.09	2.66	2.56	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	466.40	2.53	1.18	2.02	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	384.37	6.90	2.04	2.98	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	864.23	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	274.53	1.74	0.87	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	363.70	1.21	1.04	3.64	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	549.11	3.38	1.82	2.34	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	413.93	1.79	1.79	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	282.49	0.77	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	340.73	2.55	1.28	1.28	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	504.06	3.71	2.85	0.57	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	284.03	3.58	1.10	0.00	4.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	286.55	3.20	1.60	0.23	2.51
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	348.91	4.16	1.59	0.79	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	249.00	1.59	1.06	0.26	3.70
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	247.87	2.28	1.96	1.63	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	453.72	3.10	2.21	0.44	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	392.73	2.26	1.27	1.13	2.83
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	355.64	1.85	0.99	1.11	2.59
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	345.45	3.22	1.61	0.27	2.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	275.17	2.35	0.62	0.50	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	312.57	2.49	0.42	0.55	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	264.50	2.03	1.22	0.41	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	264.92	1.60	1.83	0.00	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	274.29	2.62	1.00	0.37	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	297.92	2.19	1.75	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	297.84	1.48	1.48	0.59	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	312.51	2.54	1.43	0.64	2.86
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	299.83	1.79	1.12	0.22	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	283.50	2.02	1.81	0.40	1.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	381.69	5.09	1.87	0.68	2.88
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	536.29	2.48	2.39	0.89	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	425.80	1.77	1.77	0.73	2.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	424.55	1.54	1.02	0.34	2.39
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	359.96	2.32	3.32	1.11	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	476.46	1.50	3.08	0.92	2.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	490.85	2.25	2.25	1.02	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	318.33	1.65	2.06	0.00	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	344.15	2.54	2.19	0.35	2.88
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	363.21	2.00	2.84	0.17	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	285.24	2.65	0.88	0.66	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	342.53	3.20	2.21	0.49	1.97
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	367.46	1.30	1.62	0.97	2.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	325.53	2.57	1.60	0.00	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	323.30	1.33	2.65	0.19	1.61
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	310.34	3.01	1.74	0.79	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	322.64	3.65	2.13	1.22	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	342.99	2.09	2.72	0.84	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	319.01	2.20	2.20	1.76	1.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	330.77	3.09	1.40	0.84	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	406.55	1.94	3.80	1.67	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	346.29	3.48	1.87	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	381.75	3.37	4.13	1.38	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	340.42	2.72	4.02	1.94	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	397.39	2.71	4.07	0.81	2.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	364.83	2.58	2.40	1.66	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	345.86	3.51	2.85	0.88	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	425.46	3.97	1.98	0.99	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	354.58	2.64	1.58	1.45	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	328.46	2.82	2.02	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	567.54	1.02	4.83	0.00	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	820.53	6.17	2.99	0.40	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	365.62	2.16	2.16	0.15	1.69
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	532.73	1.64	1.64	0.20	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	318.25	2.50	0.00	0.00	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	280.58	1.70	1.13	0.57	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	370.81	6.92	1.38	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	319.25	9.90	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	386.04	5.03	2.71	1.55	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	351.38	6.42	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	281.69	6.96	0.00	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	341.43	3.91	1.95	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	387.09	2.88	1.65	2.06	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	239.92	16.66	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	324.67	3.64	0.84	0.28	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	324.88	2.94	1.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	245.78	6.71	0.84	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	333.02	4.45	0.95	0.95	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	296.86	3.06	1.36	0.34	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	217.17	6.26	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	292.08	4.01	1.72	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	204.82	1.78	0.89	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	288.00	13.55	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	344.21	2.90	1.66	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	324.02	2.99	2.30	0.92	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	289.77	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	269.86	3.84	1.92	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	284.25	2.93	1.30	0.00	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	173.23	5.35	0.67	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	281.63	5.39	0.77	0.00	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	347.47	5.48	3.08	0.34	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	206.24	9.94	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	238.28	6.13	0.94	0.00	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	213.64	4.22	1.81	0.00	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	247.22	4.07	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	249.27	3.19	1.20	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	310.81	3.95	0.99	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	252.61	5.90	3.54	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	230.46	1.75	1.17	0.00	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	312.48	4.39	1.76	0.00	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	213.62	5.93	1.70	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	229.22	3.58	2.98	0.00	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	292.60	4.37	2.43	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	305.87	2.28	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	222.46	3.74	0.42	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	244.01	2.25	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	150.65	0.63	0.95	1.27	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	154.56	0.84	1.25	1.25	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	531.59	4.99	2.79	2.44	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	584.05	3.54	2.03	4.39	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	583.09	4.10	2.73	4.10	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	506.21	5.68	2.95	2.51	1.53
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	561.78	3.22	3.44	4.08	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	548.75	4.52	2.80	6.24	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	524.68	5.85	3.61	4.48	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	543.64	5.49	3.09	4.12	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	556.17	3.20	1.92	5.45	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	194.75	1.68	2.24	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	62.32	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	288.17	15.86	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	182.00	0.71	0.35	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	63.93	0.73	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	396.53	5.25	2.10	0.70	0.52
Hepatocyte, donor1	11523-119I2	861.95	18.16	4.84	0.00	1.21
Hepatocyte, donor2	11603-120I1	1115.04	18.31	6.46	2.15	1.08
Hepatocyte, donor3	11684-122I1	1034.42	19.63	6.14	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	306.11	1.31	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	732.68	2.62	4.02	0.52	3.15
Iris Pigment Epithelial Cells, donor1	11530-119I9	342.19	1.51	2.33	1.51	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	149.64	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	166.88	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	216.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	192.43	0.00	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	135.14	2.50	0.00	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	171.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	150.84	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	204.67	3.25	0.00	6.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	153.39	1.67	1.67	6.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	163.38	3.63	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	198.52	0.00	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	152.99	1.11	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	162.39	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	175.73	0.63	0.00	2.52	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	167.04	3.09	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	204.89	14.63	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	170.55	1.29	1.29	4.52	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	181.92	0.00	0.00	6.44	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	179.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	193.94	2.44	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	194.79	1.26	0.42	2.10	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	186.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	198.51	2.41	0.00	4.02	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	184.66	0.92	1.85	3.69	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	180.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	174.65	1.89	0.47	3.30	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	200.44	1.81	0.00	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	368.56	0.00	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	200.16	1.08	0.00	3.23	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	198.19	2.54	1.27	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	213.59	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	185.56	0.64	0.64	4.46	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	205.96	1.82	0.00	7.29	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	162.09	0.71	0.71	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	202.42	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	271.03	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	206.49	0.93	1.23	3.40	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	212.48	0.00	0.00	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	166.59	0.00	3.14	6.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	216.96	0.70	0.00	4.17	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	152.70	0.00	0.00	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	132.92	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	161.31	0.87	0.87	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	143.99	0.00	2.25	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	160.29	0.00	0.00	3.48	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	102.41	1.07	0.00	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	123.30	0.00	0.00	1.39	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	170.98	0.00	0.00	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	143.59	0.00	0.00	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	160.34	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	223.51	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	117.37	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	230.27	0.57	0.90	2.12	0.16
Keratinocyte - epidermal, donor2	11349-117G8	158.12	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	310.94	2.84	1.14	0.28	0.09
Keratinocyte - oral, donor1	11251-116E9	347.02	1.25	1.02	0.23	0.34
Keratocytes, donor1	11527-119I6	324.23	1.03	1.38	0.00	1.72
Keratocytes, donor2	11607-120I5	86.71	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	483.92	3.16	4.94	0.40	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	749.49	0.00	4.40	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	239.48	1.08	2.16	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	448.06	1.04	1.61	0.69	0.69
Lens Epithelial Cells, donor3	11690-122I7	628.87	1.92	3.83	3.23	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	283.04	1.42	1.66	0.59	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	190.05	1.40	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	303.65	4.88	2.20	0.94	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	193.04	0.54	0.54	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	168.93	3.78	1.58	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	165.82	1.62	1.29	0.54	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	226.54	0.00	1.23	1.64	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	119.84	0.51	0.00	0.76	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	173.12	2.82	0.99	1.55	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	193.42	1.98	0.79	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	198.54	1.36	1.16	1.74	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	100.35	2.41	0.37	0.93	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	222.64	2.44	2.09	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	194.87	1.43	0.48	2.39	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	157.95	2.75	0.82	0.55	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	242.67	2.77	0.92	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	114.72	1.87	0.62	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	175.49	0.91	0.73	1.28	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	209.97	1.65	1.32	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	125.35	1.17	0.59	1.76	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	127.45	2.24	1.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	223.57	1.45	1.45	2.42	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	189.05	1.62	0.54	1.08	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	199.52	2.12	1.06	1.67	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	202.70	1.04	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	234.31	2.51	1.26	1.47	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	166.31	1.95	0.75	1.20	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	230.44	2.06	0.69	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	166.14	1.32	0.94	0.75	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	133.28	1.38	0.64	0.95	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	233.08	1.45	1.45	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	157.79	0.99	0.99	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	140.25	2.48	0.12	0.99	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	275.07	1.85	1.85	0.37	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	186.30	0.49	0.74	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	131.31	1.92	0.82	0.69	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	260.21	1.61	1.29	0.64	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	218.81	2.43	1.83	1.83	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	228.00	2.66	1.82	1.40	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	234.67	2.13	0.36	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	124.59	2.42	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	107.06	2.02	1.09	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	206.63	0.36	1.43	1.79	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	154.84	0.33	0.65	0.33	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	106.18	1.18	0.71	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	287.10	1.61	1.61	1.36	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	114.49	0.77	0.00	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	147.39	2.39	1.79	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	226.60	2.27	2.27	4.53	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	195.62	2.30	0.77	3.84	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	197.43	0.74	2.23	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	181.52	5.50	0.00	0.42	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	142.77	0.70	1.41	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	141.03	3.74	0.00	0.93	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	169.52	8.76	0.00	1.03	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	127.27	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	196.79	1.13	1.58	1.13	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	273.96	4.94	1.74	0.87	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	290.36	1.80	0.90	2.25	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	248.62	1.35	1.22	1.08	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	178.71	2.57	2.57	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	286.17	3.53	2.12	0.71	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	251.86	0.67	2.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	190.00	4.58	1.02	0.00	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	293.22	2.13	2.67	0.53	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	302.69	4.72	2.27	1.13	2.46
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	154.00	3.07	0.61	0.61	4.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	202.22	3.26	1.63	0.82	4.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	297.37	4.79	2.92	1.46	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	298.76	8.97	3.64	1.68	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	209.16	6.18	2.06	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	320.50	6.68	2.32	1.74	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	256.18	4.19	1.49	0.90	2.69
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	287.14	1.66	2.77	0.00	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	232.59	1.41	1.77	0.71	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	234.91	4.43	1.48	1.11	4.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	178.45	1.15	6.91	1.15	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	205.31	1.92	0.38	0.38	3.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	187.39	5.66	1.13	1.13	5.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	210.04	5.74	2.46	1.64	4.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	205.16	4.52	0.90	0.90	4.97
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	198.21	6.46	2.15	0.00	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	240.50	2.99	2.99	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	235.22	4.83	3.34	1.11	4.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	260.17	3.88	0.86	0.86	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	234.63	4.28	1.71	0.00	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	229.23	3.33	1.33	1.00	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	222.02	3.62	1.81	0.00	4.22
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	180.59	1.42	1.42	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	202.79	3.09	1.03	0.34	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	210.94	5.37	0.54	0.54	3.76
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	176.42	2.69	0.00	0.00	4.04
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	230.02	3.33	1.85	0.37	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	253.52	1.16	4.65	0.00	4.65
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	156.55	1.06	2.12	2.12	4.23
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	245.69	4.00	0.80	0.00	4.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	170.09	0.73	1.45	1.45	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	184.73	0.77	1.53	0.00	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	168.70	5.43	1.97	0.99	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	154.31	1.88	0.94	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	169.95	1.51	1.01	1.51	3.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	202.78	1.80	1.80	1.80	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	163.50	3.44	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	183.04	4.45	1.78	0.89	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	199.81	1.96	1.56	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	171.53	1.98	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	199.27	0.52	0.52	1.56	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	240.66	4.81	2.19	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	212.46	3.35	0.56	2.24	2.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	211.10	2.21	3.53	0.44	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	229.89	4.24	1.16	0.77	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	215.20	4.05	2.03	1.52	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	211.47	2.88	1.92	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	221.43	7.16	1.19	0.80	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	212.06	3.04	0.00	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	194.37	2.77	0.69	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	204.82	7.22	0.38	1.52	3.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	214.31	4.65	2.58	0.52	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	181.40	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	230.70	3.17	1.27	1.58	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	160.46	1.07	0.53	1.07	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	144.82	2.30	2.30	0.57	5.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	194.89	5.14	2.57	0.51	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	198.77	2.12	1.41	1.41	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	161.73	2.84	1.13	0.00	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	200.52	2.50	1.25	0.83	3.74
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	189.50	4.70	3.13	0.78	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	176.62	1.25	1.67	0.42	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	198.40	4.18	1.86	0.46	4.18
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	163.92	4.01	0.67	1.34	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	235.24	0.53	1.60	0.00	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	200.43	4.04	2.02	0.40	3.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	164.28	5.51	0.92	0.92	5.51
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	211.61	1.78	1.78	0.89	6.22
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	193.76	3.99	2.28	0.57	3.99
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	151.85	1.53	0.77	0.00	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	250.61	2.19	1.09	0.55	4.92
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	198.22	1.34	1.34	0.89	3.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	245.92	1.82	1.82	0.52	4.94
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	223.47	3.32	0.00	0.66	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	239.04	10.39	4.16	2.08	8.31
Macrophage - monocyte derived, donor1	11232-116C8	489.33	3.19	1.82	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	406.47	2.02	4.77	0.92	0.18
Macrophage - monocyte derived, donor3	11389-118C3	404.25	4.33	3.15	1.18	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	270.82	1.06	1.59	3.19	0.53
Mallassez-derived cells, donor2	11929-125I3	662.65	4.75	2.54	5.07	0.00
Mallassez-derived cells, donor3	11930-125I4	423.49	1.81	0.69	4.86	0.00
Mammary Epithelial Cell, donor1	11273-116H4	523.83	1.79	2.79	0.90	0.40
Mammary Epithelial Cell, donor2	11350-117G9	388.58	2.03	2.03	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	165.87	1.50	0.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	1037.92	2.03	8.14	4.75	0.00
Mast cell, donor1	11563-120D6	486.20	2.16	5.84	1.84	1.51
Mast cell, donor2	11565-120D8	767.30	2.67	2.97	0.00	2.08
Mast cell, donor3	11566-120D9	765.87	2.70	3.60	0.23	1.80
Mast cell, donor4	11567-120E1	686.64	2.13	3.55	0.00	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	714.37	3.55	5.77	1.11	1.66
Mast cell, expanded and stimulated, donor8	11942-126A7	414.41	1.75	0.58	2.92	1.17
Mast cell, expanded, donor5	11939-126A4	476.67	2.41	1.61	1.84	1.15
Mast cell, expanded, donor8	11941-126A6	399.84	3.18	1.84	3.51	2.18
Melanocyte - dark, donor1	11502-119F8	441.27	1.59	2.29	0.99	0.40
Melanocyte - dark, donor2	11582-120F7	314.24	3.11	1.04	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	555.33	2.03	9.34	0.87	0.43
Melanocyte - light, donor1	11274-116H5	209.45	1.18	1.88	0.47	0.00
Melanocyte - light, donor2	11351-117H1	109.88	1.36	0.68	0.00	1.36
Melanocyte - light, donor3	11423-118G1	151.76	0.87	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	377.35	2.39	2.50	0.73	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	451.55	4.30	5.11	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	329.46	1.61	1.61	0.54	0.80
Meningeal Cells, donor1	11493-119E8	441.78	0.99	1.74	0.25	0.25
Meningeal Cells, donor2	11573-120E7	482.40	2.20	1.76	1.32	0.00
Meningeal Cells, donor3	11654-122E7	548.02	2.61	1.71	1.06	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	263.20	0.29	0.86	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	463.11	2.11	4.63	3.42	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	28.91	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	54.94	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	277.71	3.59	0.72	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	418.24	1.69	3.18	0.85	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	358.89	2.01	0.50	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	134.49	0.44	0.22	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	116.16	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	95.14	0.82	0.20	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	350.84	1.80	0.97	0.55	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	68.77	0.00	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	474.19	1.84	1.18	0.66	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	79.82	1.19	0.59	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	79.41	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	144.73	0.00	0.00	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	422.14	1.42	3.19	1.77	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	430.93	1.56	1.88	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	274.31	2.18	0.73	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	520.01	2.92	2.65	5.30	0.53
Mesothelial Cells, donor2	12156-128G5	455.92	0.50	5.00	4.50	0.50
Mesothelial Cells, donor3	11402-118D7	284.65	3.32	1.30	4.41	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	557.68	2.70	4.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	479.00	4.43	4.19	0.99	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	323.90	2.06	4.71	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	477.08	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	354.89	4.65	2.17	0.62	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	254.52	3.11	1.87	1.04	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	463.21	2.32	6.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	356.12	2.75	2.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	358.42	3.72	4.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	700.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	302.18	1.22	2.44	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	274.01	2.77	3.56	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	667.01	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	304.42	0.00	3.54	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	245.82	1.90	2.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	463.20	3.95	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	285.02	1.91	3.82	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	238.49	0.00	2.76	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	297.76	2.98	3.87	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	256.53	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	441.34	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	256.17	2.01	3.01	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	237.91	3.57	2.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	339.47	0.55	0.55	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	284.35	2.07	1.38	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	255.56	1.89	3.16	0.84	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	247.86	1.83	1.83	1.22	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	269.89	2.15	2.15	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	273.64	0.89	2.67	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	319.87	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	245.96	1.31	1.75	1.10	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	262.60	0.51	2.03	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	387.74	3.31	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	309.84	1.63	3.53	0.82	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	266.14	1.18	2.65	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	330.37	1.09	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	254.69	3.84	0.96	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	249.74	2.40	3.20	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	324.98	0.00	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	265.31	3.00	2.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	188.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	285.39	2.04	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	274.14	2.19	0.88	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	331.10	3.31	3.31	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	331.72	0.00	1.28	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	309.40	0.74	1.24	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	339.60	2.78	2.09	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	444.18	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	299.48	2.74	3.08	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	279.64	0.00	2.63	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	330.24	0.36	2.13	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	240.99	3.65	2.24	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	285.54	1.25	1.66	1.25	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	287.88	0.00	2.91	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	246.16	1.21	1.81	1.21	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	287.17	2.50	2.09	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	425.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	263.21	5.54	1.85	2.77	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	310.17	3.98	1.71	0.57	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	261.72	1.80	2.76	0.97	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	222.35	2.85	0.78	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	328.17	1.72	0.86	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	274.40	1.91	2.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	246.87	2.40	2.40	1.33	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	296.34	2.39	1.80	0.90	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	220.78	1.27	0.85	0.99	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	215.63	2.23	1.59	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	316.44	1.33	2.43	1.33	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	262.03	1.90	2.28	1.14	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	239.79	2.56	0.85	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	283.41	2.95	2.21	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	302.38	1.30	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	280.80	2.65	2.65	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	312.26	2.31	2.88	2.88	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	368.87	1.65	0.82	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	260.26	2.38	1.49	1.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	241.08	7.53	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	267.34	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	478.07	3.61	0.99	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	282.98	5.26	2.10	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	369.87	4.55	0.59	0.59	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	347.38	1.86	1.86	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	332.72	4.88	2.25	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	259.42	1.33	2.13	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	462.81	1.47	1.58	0.23	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	258.59	2.21	0.74	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	404.17	5.50	1.47	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	329.79	15.56	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	460.15	0.53	1.07	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	185.47	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	356.51	8.08	3.03	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	255.94	2.95	2.11	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	236.98	1.36	1.36	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	299.46	2.54	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	493.19	0.81	2.43	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	135.94	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	194.15	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	270.78	0.00	6.52	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	223.37	0.00	4.75	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	150.59	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	573.71	3.23	5.39	5.39	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	411.82	5.75	2.61	0.52	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	211.59	0.00	0.00	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	210.35	1.25	0.83	4.17	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	471.93	2.47	3.80	1.90	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	713.35	3.19	3.19	4.79	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	150.27	0.68	1.36	2.04	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	812.24	0.00	9.19	11.03	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	145.65	2.09	0.00	1.26	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	229.42	0.93	1.39	4.18	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	163.22	2.97	0.27	1.62	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	335.54	1.68	1.05	2.52	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1313.90	11.13	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	181.67	0.00	0.50	1.49	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	210.31	1.35	0.81	1.35	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	130.80	1.13	0.23	0.91	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	157.42	1.31	0.82	0.82	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	334.44	3.10	1.82	0.91	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	168.15	3.18	1.06	2.12	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	175.89	2.40	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	491.61	2.30	0.98	1.64	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	123.11	1.63	0.33	0.81	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	402.86	2.12	2.47	0.71	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	161.74	3.52	0.70	2.81	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	182.96	2.30	1.38	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	175.78	2.25	0.32	0.64	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	464.22	8.97	4.83	3.10	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1319.85	15.17	15.17	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	391.65	1.34	2.01	1.34	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	195.18	1.69	1.27	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	219.55	1.42	0.95	1.42	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	184.58	0.86	0.00	2.58	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1417.36	27.08	0.00	0.00	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	169.94	1.00	0.00	0.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	370.16	2.71	0.90	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	170.23	2.38	0.40	1.59	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	204.30	1.86	0.93	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	194.86	1.14	0.76	1.51	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	179.24	0.00	0.98	2.28	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	130.30	0.44	1.31	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	372.23	1.36	0.90	3.17	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	163.15	2.65	1.76	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	162.89	3.99	0.66	2.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	163.20	1.49	0.99	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	157.72	1.15	0.38	3.06	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	296.40	3.02	1.21	1.21	3.33
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	351.65	2.43	0.66	3.76	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	191.10	4.07	0.00	2.71	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1144.53	10.22	10.22	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	139.62	1.83	0.61	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	180.66	0.94	0.63	2.83	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	117.73	1.21	0.61	0.91	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	129.75	2.37	0.00	1.58	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	600.83	18.14	5.67	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	895.25	15.17	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	472.07	4.35	4.35	6.21	0.25
Myoblast, donor2	11322-117D8	392.02	4.60	2.88	0.96	0.96
Myoblast, donor3	11398-118D3	546.53	2.02	5.89	5.89	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	431.52	2.63	2.92	0.73	2.19
Natural Killer Cells, donor1	11230-116C6	292.45	2.15	3.38	0.62	0.62
Natural Killer Cells, donor2	11311-117C6	201.74	1.81	1.51	0.00	0.60
Natural Killer Cells, donor3	11387-118C1	214.05	1.84	2.21	0.37	0.92
Neural stem cells, donor1	11275-116H6	993.37	2.18	3.63	3.27	2.54
Neural stem cells, donor2	11352-117H2	820.32	1.93	3.85	9.63	1.93
Neurons, donor1	11494-119E9	333.40	3.41	2.28	4.55	0.00
Neurons, donor2	11574-120E8	378.02	2.20	1.54	0.66	1.32
Neurons, donor3	11655-122E8	241.72	1.64	2.47	1.64	1.64
Neutrophils, donor1	11233-116C9	180.96	1.86	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	124.65	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	202.80	1.22	0.00	1.83	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	482.18	2.49	2.37	0.24	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	143.27	1.63	1.30	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	290.40	2.01	2.01	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	218.73	1.65	0.28	1.24	0.41
Olfactory epithelial cells, donor2	11934-125I8	274.73	6.37	1.30	1.01	0.43
Olfactory epithelial cells, donor3	11935-125I9	243.13	2.84	0.79	1.59	0.91
Olfactory epithelial cells, donor4	11936-126A1	328.13	2.82	1.17	0.88	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	378.54	0.60	1.81	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	318.40	1.06	2.98	0.43	1.49
Osteoblast - differentiated, donor2	11353-117H3	96.02	3.43	2.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	263.18	1.86	0.62	1.24	1.86
Osteoblast, donor1	11277-116H8	282.60	0.98	1.17	1.95	0.20
Osteoblast, donor2	11354-117H4	653.86	4.92	4.92	3.51	0.00
Osteoblast, donor3	11426-118G4	416.07	4.09	2.31	1.60	0.36
Pancreatic stromal cells, donor1	11249-116E7	504.32	3.03	2.78	2.11	0.51
Pericytes, donor1	11491-119E6	56.30	0.11	0.11	0.00	0.45
Pericytes, donor2	11571-120E5	71.08	0.45	0.45	0.00	0.68
Pericytes, donor3	11652-122E5	156.45	1.42	0.61	0.61	0.41
Perineurial Cells, donor1	11499-119F5	451.41	1.02	1.92	0.79	0.79
Perineurial Cells, donor2	11579-120F4	451.77	1.56	1.75	1.10	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	422.33	0.64	1.91	1.27	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	235.80	2.20	0.98	0.73	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	249.77	1.68	1.16	0.26	0.52
Placental Epithelial Cells, donor1	11278-116H9	125.80	0.00	0.96	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	151.92	1.11	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	119.56	0.39	0.79	0.20	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	257.28	3.48	2.22	2.22	0.00
Preadipocyte - breast, donor1	11467-119B9	462.22	4.13	1.69	4.69	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	608.78	1.44	4.70	4.83	0.00
Preadipocyte - breast, donor2	11328-117E5	398.06	4.73	2.70	2.03	0.23
Preadipocyte - omental, donor1	11468-119C1	594.28	3.20	3.30	6.29	0.96
Preadipocyte - omental, donor2	11329-117E6	487.10	3.93	3.06	4.80	0.87
Preadipocyte - omental, donor3	11403-118D8	523.14	4.30	5.73	4.87	1.15
Preadipocyte - perirenal, donor1	11469-119C2	325.79	0.00	2.95	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	272.11	0.92	0.92	1.84	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	518.48	4.43	2.30	1.24	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	349.42	2.72	2.21	1.19	0.17
Preadipocyte - visceral, donor1	11280-116I2	626.42	2.14	2.33	2.42	0.75
Preadipocyte - visceral, donor2	11357-117H7	480.89	4.14	1.38	4.14	0.00
Preadipocyte - visceral, donor3	11429-118G7	373.24	1.25	2.09	1.99	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	930.76	7.24	6.34	0.15	1.51
Prostate Epithelial Cells, donor2	11331-117E8	256.47	1.90	1.76	3.25	0.14
Prostate Epithelial Cells, donor3	11404-118D9	381.88	5.45	1.65	0.67	0.61
Prostate Stromal Cells, donor1	11254-116F3	545.36	3.42	1.82	2.39	0.34
Prostate Stromal Cells, donor2	11332-117E9	460.80	5.74	3.41	1.43	0.18
Prostate Stromal Cells, donor3	11405-118E1	271.53	1.98	1.04	2.61	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	105.48	0.00	0.00	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	259.23	1.39	0.62	0.83	0.28
Renal Epithelial Cells, donor1	11517-119H5	63.40	0.00	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	89.63	0.71	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	356.87	1.91	0.53	0.64	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	77.62	0.00	0.00	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	188.94	1.48	1.21	0.54	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	458.01	4.88	2.44	2.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	57.23	0.00	0.67	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	133.81	0.22	0.22	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	119.13	0.00	0.00	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	36.62	0.55	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	301.44	0.54	0.81	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	137.05	1.27	0.00	0.42	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	113.39	0.19	0.19	0.77	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	397.48	1.81	2.07	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	229.10	2.27	0.57	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	69.98	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	374.10	1.00	0.25	1.51	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	727.11	2.94	3.47	0.80	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	687.92	6.25	0.00	2.68	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	612.01	4.40	1.65	1.10	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	762.77	4.06	4.64	0.58	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	820.46	2.99	2.99	2.86	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	513.31	3.87	2.68	4.37	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	706.82	3.35	2.34	6.02	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	698.61	4.09	3.35	5.71	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	506.39	4.89	1.86	4.31	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	627.29	7.63	3.24	4.39	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	542.30	4.24	2.33	2.60	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	499.66	5.29	2.42	5.14	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	648.67	2.33	1.08	4.66	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	477.57	2.58	3.01	4.02	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	460.92	3.54	2.04	5.58	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	531.71	3.54	2.66	5.31	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	537.01	4.40	1.91	3.63	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	513.89	2.70	1.12	5.87	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	794.47	3.19	1.88	7.14	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	605.28	3.85	2.39	4.64	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	519.22	3.50	2.24	4.67	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	537.93	1.72	1.53	7.83	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	551.05	2.99	1.17	4.49	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	462.22	6.73	1.40	4.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	558.67	4.44	2.05	5.98	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	534.59	3.28	2.92	4.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	451.53	4.29	1.10	4.17	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	554.34	3.22	2.01	5.91	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	537.79	5.90	1.89	4.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	473.02	2.78	1.98	4.96	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	575.96	3.51	2.57	7.25	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	506.57	3.73	1.66	7.26	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	507.01	8.41	1.99	6.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	527.22	2.72	1.88	6.48	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	574.54	2.42	1.35	4.31	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	553.80	3.24	2.38	6.64	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	577.03	3.28	1.54	6.17	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	545.21	4.47	1.20	7.91	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	509.86	3.43	2.74	7.82	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	561.62	5.25	3.12	5.91	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	449.08	4.77	2.90	5.45	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	475.24	2.81	2.22	5.62	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	462.20	1.33	2.40	6.40	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	534.26	3.73	3.04	1.24	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	405.73	2.38	1.90	3.57	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	597.77	2.62	1.21	4.23	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	463.81	2.17	3.01	1.88	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	678.81	6.29	4.54	2.45	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	735.59	4.84	3.63	5.14	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	585.86	3.06	2.94	3.18	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	872.30	3.64	3.64	1.89	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	648.58	4.26	4.26	3.65	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	574.77	5.43	5.43	2.71	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	771.75	6.56	5.43	2.71	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	663.48	2.70	3.89	1.50	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	1133.16	5.67	8.86	2.95	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	821.55	10.89	6.62	3.42	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	632.23	3.00	2.40	2.40	3.00
Schwann Cells, donor1	11498-119F4	78.24	0.38	0.19	0.19	0.56
Schwann Cells, donor2	11578-120F3	258.58	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	299.26	4.60	1.31	0.22	0.00
Sebocyte, donor1	11220-116B5	341.26	0.55	0.55	1.10	0.00
Sebocyte, donor2	11301-117B5	169.58	1.38	0.46	0.46	0.46
Sebocyte, donor3	11378-118B1	136.24	0.00	0.82	0.00	0.82
Sertoli Cells, donor1	11255-116F4	647.73	1.66	4.97	9.94	1.66
Sertoli Cells, donor2	11333-117F1	415.18	5.65	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	436.19	0.88	1.32	0.44	0.88
Skeletal Muscle Cells, donor2	11358-117H8	177.82	2.17	1.45	0.72	1.45
Skeletal Muscle Cells, donor3	11430-118G8	259.17	1.67	1.67	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	350.48	2.20	0.94	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	307.10	1.49	1.49	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	355.21	3.69	0.77	0.31	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	411.03	1.89	1.13	0.38	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	287.23	2.00	1.00	0.71	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	412.61	2.18	1.88	1.09	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	428.00	1.18	1.60	1.43	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	163.57	0.72	0.00	0.72	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	170.07	2.06	1.24	0.83	0.69
Skin - palm, donor1	10286-104F7	453.95	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	185.82	3.17	0.58	1.59	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	318.98	2.45	1.64	4.09	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	133.59	1.56	0.39	0.91	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	605.94	5.14	1.67	3.61	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	458.68	4.22	1.83	3.24	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	781.29	3.81	2.75	1.27	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	743.88	6.60	3.67	2.62	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	77.45	0.31	0.00	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1461.60	9.78	11.56	9.12	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	337.41	0.00	3.53	3.53	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	362.65	1.33	0.88	1.99	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	306.36	1.97	1.18	2.76	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	370.83	1.55	1.55	2.32	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	167.13	3.00	0.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	469.63	1.60	1.73	4.66	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	381.47	3.55	1.33	2.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	589.96	8.71	3.58	9.99	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	407.64	1.30	2.93	0.65	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	428.52	0.89	3.25	1.77	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	253.27	2.28	1.71	1.71	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	55.31	0.00	0.33	0.33	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	337.31	1.52	1.83	0.61	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	412.18	1.77	2.53	1.52	2.02
Smooth Muscle Cells - Carotid, donor2	11362-117I3	905.87	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	243.19	2.38	0.00	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	321.49	1.92	1.62	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	283.68	3.01	1.72	0.86	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	315.50	3.04	1.89	0.42	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	322.66	1.08	1.86	5.57	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	185.39	2.16	0.00	8.62	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	350.86	2.69	1.79	2.69	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	67.94	0.00	0.34	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	362.96	1.41	0.55	0.16	1.18
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	550.41	1.91	3.22	8.96	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	514.72	3.87	3.87	5.01	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	268.09	3.62	0.60	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	546.81	2.65	1.32	1.59	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	541.82	2.53	2.40	1.73	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	361.88	3.63	2.38	2.50	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	292.73	2.79	2.28	1.78	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	477.95	1.96	2.11	4.07	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	187.54	3.00	1.50	2.25	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	799.88	2.58	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	408.33	3.72	0.93	4.19	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	319.59	2.52	1.51	4.04	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	338.15	4.70	2.51	7.21	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	63.72	2.36	0.29	0.88	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	545.74	0.83	2.42	1.00	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	209.75	2.34	1.40	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	322.52	0.58	1.58	6.62	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	235.07	3.82	0.76	2.55	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	189.54	2.07	0.94	1.13	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	341.26	0.70	0.84	0.14	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	421.04	1.17	1.59	0.67	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	43.81	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	300.69	1.47	1.71	3.91	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	420.24	2.43	3.76	1.77	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	395.57	3.51	3.22	0.29	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	282.02	2.33	0.78	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	305.71	5.82	2.38	2.38	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	287.89	5.21	1.12	1.12	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	371.20	1.44	1.44	3.59	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	307.46	0.85	1.70	3.41	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	371.02	4.33	0.00	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	305.76	6.35	2.03	3.56	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	266.75	3.19	0.40	0.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	199.39	2.51	0.84	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	252.10	1.83	1.83	1.83	1.38
Synoviocyte, donor1	11291-117A4	338.66	2.52	0.34	2.86	0.00
Synoviocyte, donor2	11368-117I9	255.96	1.17	1.17	1.51	0.67
Synoviocyte, donor3	11440-118H9	252.68	1.56	0.67	1.34	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	130.07	0.36	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	63.43	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	83.82	0.46	0.46	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	325.66	1.36	0.57	0.36	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	120.61	0.39	0.00	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	140.30	0.00	1.15	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	738.02	3.69	2.95	0.98	1.97
Urethra, donor2	10319-105A4	402.85	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	79.96	1.06	0.53	0.80	0.00
Urothelial Cells, donor2	11600-120H7	64.89	0.00	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	61.43	0.23	0.00	0.00	0.69
Urothelial cells, donor0	11216-116B1	348.61	1.34	0.45	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	306.09	0.89	0.89	1.78	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	315.94	1.43	1.43	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	135.53	0.00	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	247.58	1.38	0.69	0.34	3.10
Whole blood (ribopure), donor090325, donation2	12177-128I8	229.51	1.16	0.58	1.16	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	257.19	0.00	0.00	0.00	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	251.48	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	142.41	2.74	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	351.70	3.33	2.22	2.47	0.12
Wilms' tumor cell line:HFWT	10597-108E3	714.59	4.40	3.52	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	432.66	1.96	2.23	1.68	0.00
achilles tendon, donor2	10292-104G4	440.17	4.13	2.07	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	547.90	4.84	3.82	0.76	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	502.43	1.39	1.63	0.46	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	313.39	0.59	2.37	0.36	1.90
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	641.10	4.90	2.45	1.09	4.08
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	559.64	8.71	0.84	1.12	5.90
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	219.94	0.63	0.42	1.90	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	449.15	2.18	1.91	1.63	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	781.25	4.85	3.53	0.88	5.29
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	488.81	7.35	2.45	2.86	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	415.09	1.16	0.78	0.39	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1026.17	10.30	3.68	1.29	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	401.75	0.00	0.00	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	439.43	2.79	1.86	2.09	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	494.50	6.47	1.29	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	655.50	9.35	1.46	1.75	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	731.53	3.25	0.93	0.93	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	528.05	3.70	0.00	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	691.25	10.13	1.53	1.84	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1204.17	4.69	2.56	2.99	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1229.86	5.76	3.34	1.82	2.73
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1332.31	4.33	4.57	2.17	1.93
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	455.05	3.34	0.89	1.11	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	410.60	2.00	0.00	5.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	668.95	5.57	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	543.14	4.90	2.64	4.90	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	636.75	2.62	0.44	0.00	3.93
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1126.55	0.00	3.75	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	730.28	6.59	1.88	2.12	1.41
adipose tissue, adult, pool1	10010-101C1	498.71	3.41	1.71	0.47	0.31
adipose, donor1	10184-103D4	505.48	5.28	4.69	0.59	3.52
adipose, donor2	10185-103D5	207.63	2.43	2.03	0.00	1.62
adipose, donor3	10186-103D6	344.72	3.54	1.36	1.09	1.91
adipose, donor4	10187-103D7	826.88	3.47	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	401.18	3.79	1.10	0.95	2.84
adrenal gland, adult, pool1	10081-102A9	291.01	3.64	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	479.60	1.20	1.33	0.53	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	825.72	7.86	1.79	2.50	0.00
amniotic membrane cells, donor1	12235-129G3	444.92	2.32	2.32	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	361.77	2.03	1.69	0.34	1.35
amniotic membrane cells, donor3	12237-129G5	441.90	3.83	3.83	0.29	0.29
amygdala - adult, donor10196	10167-103B5	339.14	2.37	2.37	2.37	4.74
amygdala, adult, donor10252	10151-102I7	462.31	4.66	3.45	1.01	4.06
amygdala, newborn, donor10223	10360-105E9	307.60	1.29	1.29	0.97	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	432.28	1.91	2.04	0.38	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	731.59	7.94	3.97	3.97	3.97
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	572.21	3.67	5.34	2.34	0.67
aorta, adult, pool1	10052-101G7	345.78	4.12	1.57	0.20	1.57
appendix, adult	10189-103D9	399.37	3.88	1.94	0.39	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	864.65	5.50	2.41	2.75	2.75
artery, adult	10190-103E1	203.80	4.08	2.72	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	445.18	2.46	2.03	1.45	0.14
b cell line:RPMI1788	10427-106D4	587.82	2.23	3.42	0.00	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	541.02	6.10	2.77	6.94	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	826.50	2.28	1.98	2.38	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	995.57	5.02	4.02	1.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	499.40	2.80	1.68	0.00	1.68
bladder, adult, pool1	10011-101C2	488.45	3.48	1.85	0.11	1.30
blood, adult, pool1	10053-101G8	177.17	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	548.06	0.00	1.71	4.28	0.00
bone marrow, adult	10192-103E3	487.22	7.42	3.37	3.37	0.67
brain, adult, donor1	10084-102B3	268.57	2.05	1.03	3.08	1.03
brain, adult, pool1	10012-101C3	393.21	2.45	3.12	1.67	1.56
brain, fetal, pool1	10085-102B4	267.14	5.34	2.67	0.00	5.34
breast carcinoma cell line:MCF7	10482-107A5	883.39	10.57	1.98	0.33	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	744.07	1.50	4.49	0.37	1.87
breast, adult, donor1	10080-102A8	364.92	3.16	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	543.60	4.57	1.02	0.13	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	482.69	3.40	3.40	0.31	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	574.63	4.83	0.00	0.69	4.14
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	608.36	4.60	5.57	3.39	1.45
carcinoid cell line:NCI-H1770	10703-109H1	338.05	3.29	0.94	0.47	4.23
carcinoid cell line:NCI-H727	10735-110B6	884.23	5.36	3.83	0.33	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	303.90	3.49	1.90	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	949.46	9.85	5.59	0.27	0.80
caudate nucleus - adult, donor10196	10177-103C6	405.27	2.30	1.15	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	468.51	3.18	2.18	1.34	4.85
caudate nucleus, adult, donor10258	10379-105H1	343.10	2.29	3.06	1.53	6.88
caudate nucleus, newborn, donor10223	10354-105E3	397.73	0.73	0.37	2.93	2.20
cerebellum - adult, donor10196	10173-103C2	393.29	0.00	11.65	0.00	8.74
cerebellum, adult, donor10252	10166-103B4	412.08	3.20	2.14	1.49	7.90
cerebellum, adult, pool1	10083-102B2	228.01	2.41	1.72	0.34	4.83
cerebellum, newborn, donor10223	10357-105E6	387.74	0.00	0.83	3.32	13.28
cerebral meninges, adult	10188-103D8	465.45	4.54	3.03	2.02	3.53
cerebrospinal fluid, donor2	10294-104G6	265.31	3.65	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	1657.96	5.18	7.05	2.59	4.03
cervical cancer cell line:ME-180	10553-107I4	490.19	0.83	3.31	0.99	0.33
cervix, adult, pool1	10013-101C4	517.18	2.10	2.10	0.21	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	1317.59	6.69	8.36	1.95	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	526.42	1.31	0.00	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	1234.93	6.34	3.11	0.62	0.62
choriocarcinoma cell line:SCH	10785-110H2	733.85	5.54	2.22	0.49	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	1386.54	7.83	3.08	2.85	0.47
chorionic membrane cells, donor1	12238-129G6	447.89	5.13	4.56	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	482.04	2.88	4.18	0.60	0.30
chorionic membrane cells, donor3	12240-129G8	591.25	7.14	3.30	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	241.34	5.05	1.01	5.05	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	534.61	4.42	2.11	3.84	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	561.54	4.22	1.90	3.17	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	626.34	1.03	1.54	7.45	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	672.66	1.69	1.45	8.71	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	641.17	3.26	1.43	8.55	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	919.29	5.01	1.77	18.55	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	745.91	1.04	4.43	5.47	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	520.71	8.46	1.37	1.14	0.23
clear cell carcinoma cell line:TEN	10636-108I6	1235.54	9.37	2.78	0.87	0.17
colon carcinoma cell line:CACO-2	10513-107D9	820.76	2.38	3.29	1.65	0.37
colon carcinoma cell line:COLO-320	10420-106C6	907.25	2.28	1.14	0.38	0.00
colon, adult, donor1	10082-102B1	347.49	4.76	2.38	1.19	0.00
colon, adult, pool1	10014-101C5	485.17	2.12	4.23	0.82	0.35
colon, fetal, donor1	10070-101I7	370.79	2.47	1.24	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	980.87	0.00	4.58	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	650.95	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1004.97	3.82	11.90	0.85	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	892.61	4.23	8.75	1.96	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	1005.41	4.37	12.83	2.12	1.83
corpus callosum, adult, pool1	10042-101F6	654.64	2.65	2.76	0.88	9.40
cruciate ligament, donor2	10295-104G7	397.94	1.62	1.62	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	262.44	4.01	0.80	0.00	0.00
diencephalon, adult	10193-103E4	362.14	4.32	1.68	2.88	2.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	330.64	3.67	0.46	0.00	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	956.01	3.08	1.28	2.31	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	753.70	3.85	4.81	0.24	2.41
ductus deferens, adult	10196-103E7	647.34	10.47	4.49	0.00	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	423.43	2.88	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	559.09	22.07	3.68	0.00	2.21
dura mater, adult, donor1	10041-101F5	685.14	2.81	3.55	1.16	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	346.21	1.11	2.22	1.55	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	558.84	2.44	2.58	1.72	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	1195.62	3.08	0.00	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	807.33	9.69	1.21	1.21	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	1383.20	4.01	1.23	2.16	0.31
embryonic pancreas cell line:2C6	10603-108E9	1442.19	11.82	1.31	5.25	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	941.56	2.35	4.36	5.03	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	458.89	2.72	0.72	1.09	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	204.88	1.45	0.32	1.29	0.00
epidermoid carcinoma cell line:A431	10426-106D3	628.94	2.22	2.11	0.33	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	661.89	2.20	2.64	1.10	0.11
epididymis, adult	10197-103E8	498.16	10.88	3.98	0.63	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	621.65	4.26	3.19	0.71	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1249.33	6.69	5.51	3.15	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	645.29	5.77	1.97	7.60	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	622.11	4.23	2.26	4.63	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	648.99	5.04	2.58	5.49	0.34
esophagus, adult, pool1	10015-101C6	351.56	2.55	1.27	0.11	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	699.44	1.00	6.89	0.63	0.50
eye - muscle inferior rectus, donor1	10272-104E2	330.80	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	256.71	4.21	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	388.42	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	416.18	3.44	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	444.50	2.91	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	468.05	4.83	1.78	0.25	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	319.28	2.18	1.15	1.41	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	859.70	7.36	1.42	3.32	0.71
frontal lobe, adult, pool1	10040-101F4	480.38	1.78	2.91	3.10	4.41
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	997.73	10.51	8.11	1.80	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	1155.85	3.20	4.85	4.85	0.55
gall bladder, adult	10198-103E9	384.60	2.41	1.93	0.72	0.97
gamma delta positive T cells, donor1	11937-126A2	404.25	0.54	1.07	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	328.67	2.24	0.37	0.37	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	574.09	7.60	4.86	2.11	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	1443.27	10.83	5.80	1.35	0.19
gastric cancer cell line:AZ521	10549-107H9	741.90	1.31	1.80	2.13	1.15
gastric cancer cell line:GSS	10560-108A2	716.62	3.66	0.00	3.66	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	1028.06	12.79	7.54	0.91	1.83
giant cell carcinoma cell line:LU65	10487-107B1	683.05	4.36	2.52	1.15	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	763.48	2.66	3.64	0.70	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	592.62	4.99	2.00	4.49	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	942.27	4.01	2.53	4.96	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	1028.01	4.63	3.79	4.63	0.70
glioblastoma cell line:T98G	10485-107A8	851.64	3.53	3.42	2.54	0.22
glioma cell line:GI-1	10413-106B8	1418.99	4.98	6.44	1.46	2.05
globus pallidus - adult, donor10196	10175-103C4	346.96	1.46	1.46	2.19	5.83
globus pallidus, adult, donor10252	10161-103A8	595.35	5.37	5.37	0.98	7.81
globus pallidus, adult, donor10258	10367-105F7	277.95	15.06	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	334.67	4.26	0.00	0.00	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	1274.96	2.45	4.89	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	426.21	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	271.78	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	396.47	2.24	2.24	2.24	0.96
hIPS +CCl2, biol_rep1	14383-156B9	502.73	1.38	0.92	0.46	1.84
hIPS +CCl2, biol_rep2	14384-156C1	463.66	3.20	0.91	0.46	3.20
hIPS +CCl2, biol_rep3	14385-156C2	447.64	1.29	0.64	0.64	3.22
hIPS, biol_rep1	14380-156B6	572.04	4.31	0.00	1.44	1.44
hIPS, biol_rep2	14381-156B7	497.94	4.80	0.69	1.37	1.37
hIPS, biol_rep3	14382-156B8	459.04	4.41	4.41	1.10	3.31
hairy cell leukemia cell line:Mo	10712-109I1	533.88	7.47	4.60	0.57	2.01
heart - mitral valve, adult	10205-103F7	368.93	4.19	1.79	0.00	1.49
heart - pulmonic valve, adult	10206-103F8	351.42	2.88	2.61	0.00	1.05
heart - tricuspid valve, adult	10207-103F9	760.20	0.83	0.83	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	308.13	5.51	1.02	1.63	1.02
heart, adult, diseased, donor1	10051-101G6	301.92	6.39	0.85	1.70	0.43
heart, adult, pool1	10016-101C7	505.95	1.38	3.22	0.23	1.15
heart, fetal, pool1	10046-101G1	575.52	2.77	3.39	0.31	1.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	630.01	4.63	5.24	3.39	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	1086.91	3.57	5.95	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	736.57	6.63	5.41	2.54	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	737.95	6.07	5.95	1.70	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	748.40	4.55	5.56	2.32	0.20
hepatoma cell line:Li-7	10484-107A7	1159.31	5.78	6.01	2.34	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	456.07	3.62	1.71	0.30	3.92
hippocampus - adult, donor10196	10169-103B7	341.62	3.79	1.89	3.79	5.68
hippocampus, adult, donor10252	10153-102I9	489.43	5.92	4.29	0.82	4.90
hippocampus, adult, donor10258	10374-105G5	305.24	1.49	0.50	1.00	2.49
hippocampus, newborn, donor10223	10363-105F3	243.21	1.06	0.35	2.11	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	598.14	8.54	1.83	1.83	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	329.48	3.34	0.79	0.00	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	421.72	2.29	1.27	1.02	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	199.61	2.26	1.13	0.00	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	198.31	6.46	1.03	0.26	2.58
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	243.33	3.42	0.38	0.00	2.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	309.76	5.55	0.29	0.58	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	305.26	5.17	1.29	0.43	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	283.61	1.25	0.00	0.83	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	568.30	3.79	2.37	1.18	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	456.28	6.75	2.09	2.09	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	517.10	3.37	0.67	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	309.53	3.29	1.25	0.63	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	340.47	7.37	0.49	0.49	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	524.52	5.24	0.00	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	219.55	2.48	0.57	0.00	5.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	212.37	1.74	0.87	0.00	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	281.87	3.50	1.50	0.50	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	322.15	5.65	1.51	0.19	3.39
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	361.50	2.27	3.64	0.00	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	315.12	4.07	0.94	0.31	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	371.84	5.55	0.98	0.98	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	395.98	4.94	2.03	0.87	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	367.97	2.99	1.20	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	302.98	3.69	0.55	0.74	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	306.11	2.28	0.57	0.29	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	539.79	2.45	1.22	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	259.84	4.93	1.06	0.35	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	203.98	2.22	0.32	0.32	4.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	212.44	3.03	0.00	0.00	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	249.25	2.59	0.52	0.00	4.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	249.06	1.99	1.99	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	289.88	2.57	0.00	0.00	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	385.77	2.81	0.77	2.56	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	397.54	2.27	2.27	3.03	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	373.36	3.70	1.01	1.01	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	329.66	3.38	0.97	0.72	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	401.54	1.34	0.89	0.89	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	383.91	1.95	0.00	0.00	4.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	233.19	2.44	0.61	0.00	4.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1054.05	29.28	6.51	0.00	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	298.51	3.64	0.00	0.00	5.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	293.35	4.93	2.19	0.00	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	279.01	1.81	1.45	0.00	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	253.74	2.85	0.36	0.00	4.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	338.92	3.58	0.00	2.39	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	692.57	4.06	3.52	1.22	1.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	374.19	3.23	1.35	2.16	2.16
immature langerhans cells, donor1	11904-125F5	466.86	2.91	4.36	0.48	0.00
immature langerhans cells, donor2	11905-125F6	229.72	3.17	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	496.92	1.61	3.69	4.16	3.79
keratoacanthoma cell line:HKA-1	10791-110H8	446.10	1.95	2.28	0.65	0.00
kidney, adult, pool1	10017-101C8	713.71	3.30	2.90	1.00	1.20
kidney, fetal, pool1	10045-101F9	592.62	2.41	2.19	0.78	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	1315.40	3.83	2.98	3.27	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	584.35	5.67	1.24	3.04	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	825.57	2.75	1.47	1.28	2.20
left atrium, adult, donor1	10079-102A7	247.36	2.18	2.72	0.00	0.00
left ventricle, adult, donor1	10078-102A6	264.96	1.01	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	495.51	3.83	2.46	2.74	0.27
leiomyoma cell line:10964C	10569-108B2	243.57	4.67	1.80	3.59	1.08
leiomyoma cell line:15242A	10570-108B3	314.13	6.52	2.17	8.15	0.00
leiomyoma cell line:15425	10571-108B4	335.81	4.86	3.16	2.43	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	482.55	6.35	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	424.49	3.14	3.14	8.36	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	635.51	2.95	4.01	10.15	0.47
liposarcoma cell line:KMLS-1	10782-110G8	672.02	4.69	2.66	1.87	0.31
liposarcoma cell line:SW 872	10726-110A6	372.58	2.19	1.83	2.80	0.61
liver, adult, pool1	10018-101C9	1174.46	4.05	6.00	1.30	0.49
liver, fetal, pool1	10086-102B5	407.33	6.58	2.82	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	446.08	4.08	2.04	3.65	5.69
locus coeruleus, adult, donor10252	10165-103B3	518.77	5.72	3.88	2.58	5.17
locus coeruleus, adult, donor10258	10375-105G6	314.87	5.08	2.26	5.36	3.67
locus coeruleus, newborn, donor10223	10362-105F2	522.83	7.99	0.84	4.63	7.57
lung adenocarcinoma cell line:A549	10499-107C4	1828.47	3.60	4.98	3.18	0.97
lung adenocarcinoma cell line:PC-14	10408-106B3	479.83	0.69	2.76	3.45	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	501.43	2.90	0.66	1.05	0.13
lung, adult, pool1	10019-101D1	533.82	3.19	2.95	0.71	1.42
lung, fetal, donor1	10068-101I5	846.52	3.42	1.14	0.29	0.86
lung, right lower lobe, adult, donor1	10075-102A3	300.59	6.42	1.37	0.00	0.46
lymph node, adult, donor1	10077-102A5	300.59	4.26	0.95	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	669.59	5.04	2.63	0.44	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	523.87	2.87	2.26	0.75	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	1199.49	6.80	7.65	1.70	0.00
mature adipocyte, donor1	12231-129F8	516.36	3.11	1.78	0.44	0.89
mature adipocyte, donor2	12232-129F9	580.87	3.11	2.70	0.00	2.08
mature adipocyte, donor3	12233-129G1	480.05	1.42	2.13	0.47	0.47
mature adipocyte, donor4	12234-129G2	494.59	2.37	0.53	0.26	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	1816.01	5.48	2.62	7.39	3.57
medial frontal gyrus - adult, donor10196	10170-103B8	331.64	1.13	3.38	4.51	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	416.18	4.41	2.02	2.21	3.49
medial frontal gyrus, adult, donor10258	10368-105F8	293.23	1.59	1.27	3.18	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	421.80	3.41	2.13	4.69	4.69
medial temporal gyrus - adult, donor10196	10183-103D3	332.10	8.61	1.69	3.04	3.04
medial temporal gyrus, adult, donor10252	10156-103A3	437.82	5.94	1.70	1.27	2.97
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	209.96	1.93	1.93	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1033.46	86.12	14.35	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	250.18	1.79	0.36	2.87	1.44
medulla oblongata - adult, donor10196	10174-103C3	422.48	2.60	1.95	1.30	5.19
medulla oblongata, adult, donor10252	10155-103A2	558.69	4.49	2.79	2.01	5.42
medulla oblongata, adult, pool1	10038-101F2	650.16	2.12	3.59	3.75	7.18
medulla oblongata, newborn, donor10223	10361-105F1	480.85	3.12	0.35	3.12	4.51
medulloblastoma cell line:D283 Med	10838-111E1	649.40	5.76	1.11	2.21	3.76
medulloblastoma cell line:ONS-76	10759-110E3	755.16	4.04	0.86	1.71	0.12
melanoma cell line:COLO 679	10514-107E1	564.20	2.30	7.04	2.73	0.72
melanoma cell line:G-361	10465-106H6	393.62	2.99	3.80	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	315.14	4.52	1.99	0.36	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	509.31	1.76	1.76	1.76	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	227.08	1.30	1.30	0.52	2.33
mesenchymal precursor cell - adipose, donor1	11747-123G1	529.19	5.06	3.99	1.53	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	393.19	1.27	2.54	0.91	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	426.94	2.48	2.07	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	263.53	2.67	1.83	1.97	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	321.78	2.70	3.47	1.73	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	334.55	0.69	1.39	3.47	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	808.40	3.78	8.58	4.98	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	298.01	2.19	3.34	1.04	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	378.81	2.12	6.10	2.25	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	476.83	4.73	4.19	3.92	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	558.81	3.98	5.69	3.84	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	848.09	5.60	4.94	5.93	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	430.89	1.38	4.43	2.63	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	411.92	2.79	1.05	4.19	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	441.20	3.47	3.47	3.47	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	480.23	2.88	2.16	0.72	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	258.31	1.66	1.86	1.55	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	321.01	4.10	2.74	6.16	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	552.56	5.45	4.62	8.39	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	448.76	4.03	3.59	1.94	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	433.54	2.71	3.76	3.76	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	537.88	2.95	2.95	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	379.44	4.58	2.00	5.15	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	371.33	4.21	0.42	2.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	325.15	1.83	2.28	0.91	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	367.56	3.07	1.28	1.53	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	381.64	3.66	1.05	3.40	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	357.38	3.39	0.62	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	346.44	3.53	0.94	0.47	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	354.36	2.37	1.35	1.35	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	345.82	2.75	2.75	1.57	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	321.59	4.63	1.85	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	386.43	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	428.01	4.04	3.17	1.15	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	376.37	2.01	1.34	1.12	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	353.80	3.36	2.88	0.72	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	559.53	8.07	0.73	2.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	341.36	4.70	0.34	1.01	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	356.16	4.50	1.23	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	388.75	3.44	0.86	2.15	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	404.69	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	428.69	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	407.61	5.20	0.65	1.30	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	400.12	8.73	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	396.08	3.20	1.07	2.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	366.36	5.72	2.45	2.45	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	382.50	2.72	1.55	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	379.87	6.30	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	375.53	5.96	0.99	4.97	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	367.08	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	426.93	8.30	0.59	2.37	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	449.61	4.87	1.22	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	486.94	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	403.46	3.17	0.63	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	355.25	2.76	0.69	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	361.07	10.75	6.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	303.38	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	258.29	6.89	0.00	3.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	261.60	2.85	0.81	0.41	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	267.73	3.18	0.79	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	222.84	4.13	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	220.69	1.87	0.62	1.25	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	274.02	4.01	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	237.72	3.55	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	310.73	10.27	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	302.21	3.44	1.38	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	333.50	3.96	1.48	1.48	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	296.08	6.73	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	293.23	5.09	1.27	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	261.13	1.61	0.81	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	226.78	6.54	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	224.27	7.60	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	541.95	3.03	3.03	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	497.09	18.08	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	492.56	6.59	0.82	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	255.57	1.98	0.00	0.99	1.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	258.62	3.24	0.97	0.97	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	254.66	7.13	3.06	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	524.58	0.00	3.87	2.32	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	1130.18	3.78	0.71	4.49	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	1035.12	3.01	13.21	1.85	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	585.48	4.27	0.00	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	759.32	13.05	4.01	2.67	0.00
mesothelioma cell line:Mero-25	10850-111F4	515.18	6.13	1.13	0.68	0.23
mesothelioma cell line:Mero-41	10851-111F5	598.23	5.62	2.20	5.13	1.96
mesothelioma cell line:Mero-48a	10852-111F6	551.58	5.98	0.44	5.76	1.55
mesothelioma cell line:Mero-82	10853-111F7	716.67	11.83	6.04	0.53	0.79
mesothelioma cell line:Mero-83	10854-111F8	450.57	6.13	1.53	4.94	0.85
mesothelioma cell line:Mero-84	10855-111F9	447.16	4.30	1.52	2.53	0.25
mesothelioma cell line:Mero-95	10856-111G1	513.05	5.59	1.86	0.83	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	524.77	4.47	1.33	2.65	0.50
mesothelioma cell line:NCI-H226	10846-111E9	581.71	4.16	4.16	3.44	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	836.52	7.00	2.56	2.39	0.34
mesothelioma cell line:NCI-H28	10845-111E8	622.42	8.40	1.02	2.04	0.76
mesothelioma cell line:No36	10857-111G2	400.25	5.87	2.28	1.30	0.00
mesothelioma cell line:ONE58	10858-111G3	311.05	4.34	1.08	2.71	0.81
migratory langerhans cells, donor1	11901-125F2	587.86	3.65	1.73	1.92	0.96
migratory langerhans cells, donor2	11902-125F3	491.64	2.44	0.61	0.85	0.12
migratory langerhans cells, donor3	11903-125F4	551.54	2.15	0.90	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	947.77	18.28	7.18	1.96	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	456.09	3.60	4.87	12.08	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	880.20	4.38	2.53	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	189.53	1.14	2.09	0.95	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	752.47	3.51	3.51	1.11	0.92
myeloma cell line:PCM6	10474-106I6	920.93	6.72	5.73	0.59	1.58
myxofibrosarcoma cell line:MFH-ino	10600-108E6	363.73	2.03	3.04	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	365.80	2.55	2.94	1.57	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	618.63	1.89	2.01	0.67	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	615.17	3.24	2.06	0.88	0.51
nasal epithelial cells, donor2	12227-129F4	619.88	1.66	1.66	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	1225.53	3.68	3.91	0.92	0.46
neuroblastoma cell line:NB-1	10539-107G8	834.03	2.25	5.43	1.31	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	831.96	4.64	3.37	1.05	0.84
neuroblastoma cell line:NH-12	10555-107I6	861.13	3.54	1.49	0.56	2.05
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	346.11	8.07	0.24	0.00	4.27
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	384.55	3.33	1.90	0.00	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	397.89	3.82	1.01	1.01	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	815.05	5.09	1.91	3.81	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	603.40	2.40	1.60	2.40	0.80
neutrophil PMN, donor1	12133-128D9	639.62	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	478.10	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	331.47	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1419.77	4.06	6.93	0.00	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	509.92	0.00	8.01	5.60	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	353.31	5.13	3.85	0.96	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	421.74	5.52	2.10	3.42	0.26
nucleus accumbens, adult, pool1	10037-101F1	511.91	2.53	3.19	2.25	4.41
occipital cortex - adult, donor10196	10172-103C1	383.23	6.18	0.00	6.18	8.24
occipital cortex, adult, donor10252	10163-103B1	457.56	6.17	4.29	1.34	7.25
occipital cortex, newborn, donor10223	10355-105E4	298.43	1.82	0.36	1.46	2.91
occipital lobe, adult, donor1	10076-102A4	277.62	2.89	2.36	1.84	2.36
occipital lobe, fetal, donor1	10073-102A1	256.17	6.01	0.43	0.86	3.00
occipital pole, adult, pool1	10036-101E9	341.38	0.47	1.58	1.50	3.47
olfactory region, adult	10195-103E6	360.32	3.44	4.20	2.29	4.20
optic nerve, donor1	10277-104E7	532.28	6.00	0.00	0.00	16.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	1064.13	3.30	4.67	1.48	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	556.55	0.96	2.47	0.27	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	528.97	7.96	2.88	1.02	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	466.54	3.35	1.73	0.81	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	483.28	3.82	1.47	1.76	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1571.55	7.47	5.61	6.54	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	1299.07	5.30	6.15	0.64	0.00
ovary, adult, pool1	10020-101D2	489.78	1.83	1.14	0.17	1.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	324.48	3.30	0.55	0.92	0.55
pancreas, adult, donor1	10049-101G4	887.02	12.23	4.70	0.94	5.64
pancreatic carcinoma cell line:NOR-P1	10698-109G5	666.97	3.63	1.40	1.96	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	562.34	9.54	2.56	3.58	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	490.45	0.83	0.83	0.33	0.33
paracentral gyrus, adult, pool1	10035-101E8	477.65	0.64	3.57	3.48	4.30
parietal cortex, adult, donor10258	10373-105G4	420.59	2.20	1.47	2.20	2.20
parietal lobe - adult, donor10196	10171-103B9	306.60	2.82	2.82	1.88	4.70
parietal lobe, adult, donor10252	10157-103A4	414.73	6.27	2.28	2.00	3.71
parietal lobe, adult, pool1	10034-101E7	461.48	1.85	3.88	3.79	3.61
parietal lobe, fetal, donor1	10072-101I9	312.29	4.85	0.97	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	296.47	2.24	0.00	1.50	4.49
parotid gland, adult	10199-103F1	1927.69	10.48	6.78	1.23	1.85
penis, adult	10200-103F2	250.29	3.22	1.61	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	667.32	6.14	1.67	1.12	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	733.72	8.89	3.21	1.60	0.00
pineal gland - adult, donor10196	10179-103C8	512.15	4.52	0.65	2.58	2.58
pineal gland, adult, donor10252	10160-103A7	843.90	5.33	3.55	2.37	5.33
pineal gland, adult, donor10258	10377-105G8	505.42	7.52	2.51	1.25	1.88
pituitary gland - adult, donor10196	10180-103C9	624.28	5.06	3.04	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	842.75	6.78	4.69	0.52	5.73
pituitary gland, adult, donor10258	10378-105G9	520.96	5.96	1.70	0.85	5.96
placenta, adult, pool1	10021-101D3	824.33	3.87	3.33	0.86	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	449.59	3.18	3.18	0.26	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	664.89	3.74	2.80	1.09	0.16
pons, adult, pool1	10033-101E6	610.56	2.15	5.59	9.30	4.65
postcentral gyrus, adult, pool1	10032-101E5	393.07	1.66	3.14	2.79	4.10
promyelocytes/myelocytes PMC, donor1	12132-128D8	2340.27	0.00	4.18	6.27	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	721.55	5.51	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	516.37	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	560.07	3.79	1.89	1.46	0.87
prostate cancer cell line:PC-3	10439-106E7	617.83	3.99	1.45	2.72	0.00
prostate, adult, pool1	10022-101D4	439.76	1.09	1.72	0.09	0.91
putamen, adult, donor10196	10176-103C5	432.70	5.19	3.78	1.89	5.19
putamen, adult, donor10252	10152-102I8	380.38	7.84	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	293.97	7.65	1.09	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	301.53	4.83	0.72	0.97	4.11
putamen, newborn, donor10223	10365-105F5	360.59	3.75	0.00	4.50	2.25
rectal cancer cell line:TT1TKB	10469-106I1	1251.89	3.78	1.45	2.62	1.45
rectum, fetal, donor1	10067-101I4	435.38	1.39	0.00	2.78	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	659.10	3.60	1.06	1.06	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	683.45	10.77	2.07	0.41	0.83
retina, adult, pool1	10030-101E3	525.23	2.29	1.99	0.99	2.39
retinoblastoma cell line:Y79	10475-106I7	487.13	2.60	1.56	0.78	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	416.18	3.32	2.46	1.11	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	709.75	2.25	1.69	0.28	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	464.56	1.52	1.52	0.76	0.76
salivary acinar cells, donor1	11771-123I7	331.81	2.27	1.94	0.49	0.65
salivary acinar cells, donor2	11772-123I8	239.44	2.07	1.65	0.00	0.96
salivary acinar cells, donor3	11773-123I9	344.93	2.65	3.31	0.00	0.66
salivary gland, adult, pool1	10093-102C3	1331.50	8.58	4.00	0.00	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	645.07	2.87	1.43	2.61	2.61
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	613.74	2.94	2.00	2.70	2.59
seminal vesicle, adult	10201-103F3	643.35	19.58	3.17	0.53	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	568.69	4.62	4.37	0.49	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	399.84	3.77	0.50	2.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	408.44	3.01	0.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	821.77	6.04	4.03	2.42	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	706.38	2.32	2.76	1.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	671.71	2.19	2.97	3.35	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	218.48	4.26	1.42	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	315.91	1.68	1.44	0.36	1.08
skeletal muscle, fetal, donor1	10066-101I3	168.84	1.01	1.01	0.00	1.01
skin, adult, donor1	10074-102A2	312.12	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	282.16	7.57	1.89	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	342.19	4.34	2.67	1.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	376.67	2.84	3.47	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	400.34	2.89	0.77	0.77	2.70
small cell lung carcinoma cell line:LK-2	10541-107H1	1158.74	3.13	8.74	4.62	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	599.97	4.50	0.16	0.48	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	624.55	5.01	3.92	4.58	0.65
small intestine, adult, pool1	10024-101D6	739.47	2.75	4.30	0.48	0.96
small intestine, fetal, donor1	10064-101I1	384.76	3.44	1.97	0.74	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	641.64	7.69	9.23	2.56	0.51
smooth muscle, adult, pool1	10048-101G3	340.90	3.36	1.03	0.00	1.03
somatostatinoma cell line:QGP-1	10781-110G7	2037.76	10.45	16.35	2.68	0.00
spinal cord - adult, donor10196	10181-103D1	416.14	6.42	0.92	0.92	4.13
spinal cord, adult, donor10252	10159-103A6	624.13	5.91	3.94	0.00	7.49
spinal cord, adult, donor10258	10369-105F9	529.92	7.61	0.00	2.08	7.61
spinal cord, fetal, donor1	10056-101H2	452.50	4.88	2.44	1.22	1.22
spinal cord, newborn, donor10223	10359-105E8	703.97	8.73	2.76	4.13	7.81
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	606.98	4.63	2.99	2.99	0.15
spleen, adult, pool1	10025-101D7	468.07	2.42	1.87	0.22	0.88
spleen, fetal, pool1	10044-101F8	417.54	1.43	1.51	0.16	1.51
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	321.41	1.35	1.45	0.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	843.43	5.32	3.42	1.33	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	421.79	5.24	2.45	0.70	3.49
squamous cell carcinoma cell line:T3M-5	10616-108G4	630.96	2.35	3.52	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	763.49	3.38	3.38	2.14	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1351.29	5.51	2.12	6.35	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	741.64	2.96	0.42	2.96	0.42
stomach, fetal, donor1	10062-101H8	634.38	1.07	2.14	0.00	0.00
submaxillary gland, adult	10202-103F4	804.96	22.79	3.42	1.14	1.71
substantia nigra - adult, donor10196	10178-103C7	922.66	379.92	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	483.33	6.02	3.53	0.42	7.06
substantia nigra, adult, donor10258	10371-105G2	459.32	2.07	2.07	4.66	3.10
substantia nigra, newborn, donor10223	10358-105E7	456.45	2.83	0.00	2.83	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	238.89	1.60	0.23	0.00	0.92
temporal lobe, adult, pool1	10031-101E4	338.66	1.61	1.86	2.03	2.71
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	229.35	5.70	0.71	2.14	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	232.52	3.96	0.88	0.44	3.96
tenocyte, donor1	11763-123H8	413.34	7.33	1.40	1.05	1.05
tenocyte, donor2	11765-123I1	233.10	2.67	1.14	1.53	1.53
tenocyte, donor3	11768-123I4	223.88	2.97	0.74	1.11	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	818.19	7.65	2.21	2.72	1.53
teratocarcinoma cell line:NCR-G1	10798-110I6	196.23	1.08	0.15	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	419.37	4.96	1.08	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	901.45	5.20	3.81	1.78	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	727.60	3.78	2.27	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	758.86	4.36	2.62	1.53	0.98
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	562.81	8.79	2.28	0.65	0.00
testis, adult, pool1	10026-101D8	483.71	4.29	6.44	0.86	29.63
testis, adult, pool2	10096-102C6	444.32	13.53	6.77	1.35	68.11
thalamus - adult, donor10196	10168-103B6	427.24	7.73	4.42	0.00	3.31
thalamus, adult, donor10252	10154-103A1	504.48	4.84	2.50	0.16	6.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	466.50	9.24	0.00	4.62	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	207.84	6.26	0.82	1.81	1.98
thalamus, newborn, donor10223	10366-105F6	344.04	4.60	0.00	4.60	0.58
throat, adult	10209-103G2	300.60	4.24	1.25	1.25	1.00
throat, fetal, donor1	10061-101H7	526.23	7.01	2.74	0.30	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	417.73	1.79	0.40	1.19	1.79
thymus, adult, pool1	10027-101D9	425.10	2.39	1.79	0.10	1.59
thymus, fetal, pool1	10043-101F7	324.29	1.04	1.97	0.21	2.81
thyroid carcinoma cell line:KHM-5M	10776-110G2	652.44	2.53	1.99	1.46	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	768.86	6.43	3.91	0.84	0.28
thyroid, adult, pool1	10028-101E1	1268.59	5.51	10.45	0.84	3.17
thyroid, fetal, donor1	10060-101H6	944.70	11.86	4.75	0.26	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	612.84	6.16	0.00	3.08	0.00
tongue, adult	10203-103F5	289.56	3.26	2.33	0.00	1.40
tongue, fetal, donor1	10059-101H5	256.95	4.34	1.97	0.79	0.39
tonsil, adult, pool1	10047-101G2	467.32	1.60	2.10	0.40	2.00
trachea, adult, pool1	10029-101E2	592.55	1.72	1.88	0.74	1.64
trachea, fetal, donor1	10058-101H4	464.33	3.85	3.08	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	499.53	6.38	2.83	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	1137.58	3.14	6.99	2.53	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	1149.30	6.74	2.51	2.19	1.72
tridermal teratoma cell line:HGRT	10694-109G1	555.54	1.90	1.90	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	770.91	5.59	3.72	1.35	0.00
umbilical cord, fetal, donor1	10057-101H3	258.73	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	658.63	2.90	2.90	0.17	0.68
uterus, fetal, donor1	10055-101H1	533.43	4.61	3.58	0.51	1.54
vagina, adult	10204-103F6	528.59	2.58	1.94	0.00	1.94
vein, adult	10191-103E2	241.99	2.19	0.66	0.88	2.41
xeroderma pigentosum b cell line:XPL 17	10563-108A5	247.28	1.87	2.67	0.00	0.27